Side-by-side comparison of AI visibility scores, market position, and capabilities
Kyruus Health connects 500K+ providers across 1,400 hospitals and 100+ health plan brands; launched AI provider matching on AWS Bedrock with Claude 3.5 Sonnet; partnered with Healthgrades and Google Cloud in 2025.
Kyruus Health is the leading care access platform in the United States, connecting patients and health plan members to the right providers through a combination of provider data management, intelligent search, and AI-powered matching. The platform serves over 500,000 providers across 1,400 hospitals, 550 medical groups, and 100+ health plan brands — making it the de facto infrastructure for provider directory management and patient-facing provider search across much of the U.S. healthcare system. Kyruus Health''s solutions include provider directory management, consumer-facing search experiences, appointment scheduling enablement, and payer-side member engagement tools.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.